Journal article · 1999 · Open access
Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics
International Journal of Antimicrobial Agents, 13(1), 15–19 · Published 1 September 1999 · DOI 10.1016/s0924-8579(99)00096-5
In brief
“Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics” is a 1999 journal article by Murat Akova and 7 co-authors, published in International Journal of Antimicrobial Agents. OpenAlex counts 38 citations as of 19 November 2026. It is open access: the full text is free to read at Dspace Repository (Marmara Üniversitesi).
- Citations
- 38
- Most cited in
- 2020 (4)
- Field-weighted impact
- 0.52
- References
- 15
- Authors
- 8
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Akova, M., Akan, H., Korten, V., Biberoğlu, K., Hayran, M., Ünal, S., Kars, A., & Kansu, E. (1999). Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics. International Journal of Antimicrobial Agents, 13(1), 15–19. https://doi.org/10.1016/s0924-8579(99)00096-5
MLA 9
Akova, Murat, et al. “Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics.” International Journal of Antimicrobial Agents, vol. 13, no. 1, 1999, pp. 15–19. https://doi.org/10.1016/s0924-8579(99)00096-5.
Chicago
Akova, Murat, Hamdi Akan, Volkan Korten, K. Biberoğlu, Mutlu Hayran, Serhat Ünal, Ayşe Kars, and Emin Kansu. 1999. “Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics.” International Journal of Antimicrobial Agents 13 (1): 15–19. https://doi.org/10.1016/s0924-8579(99)00096-5.
Harvard
Akova, M. et al. (1999) ‘Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics’, International Journal of Antimicrobial Agents, 13(1), pp. 15–19. doi:10.1016/s0924-8579(99)00096-5.
IEEE
M. Akova et al., “Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics,” International Journal of Antimicrobial Agents, vol. 13, no. 1, pp. 15–19, 1999, doi: 10.1016/s0924-8579(99)00096-5.
BibTeX
@article{akova1999comparison,
title = {{Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics}},
author = {Akova, Murat and Akan, Hamdi and Korten, Volkan and Biberoğlu, K. and Hayran, Mutlu and Ünal, Serhat and Kars, Ayşe and Kansu, Emin},
journal = {International Journal of Antimicrobial Agents},
year = {1999},
volume = {13},
number = {1},
pages = {15--19},
doi = {10.1016/s0924-8579(99)00096-5},
url = {https://doi.org/10.1016/s0924-8579(99)00096-5}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2013 | 1 | |
| 2014 | 3 | |
| 2015 | 2 | |
| 2016 | 1 | |
| 2017 | 1 | |
| 2020 | 4 | |
| 2021 | 2 | |
| 2023 | 1 | |
| 2024 | 1 |
Its field-weighted citation impact is 0.52: it has been cited 0.52 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- meropenem
- amikacin
- ceftazidime
- febrile neutropenia
- empirical antibiotic therapy
- combination antibiotic therapy
- monotherapy
- defervescence
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Akova, M., Akan, H., Korten, V., Biberoğlu, K., Hayran, M., Ünal, S., Kars, A., & Kansu, E. (1999). Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics. International Journal of Antimicrobial Agents, 13(1), 15–19. https://doi.org/10.1016/s0924-8579(99)00096-5
How many times has this paper been cited?
38 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Dspace Repository (Marmara Üniversitesi): sign in and open the full text from this page.
Who wrote this paper?
Murat Akova, Hamdi Akan, Volkan Korten, K. Biberoğlu, Mutlu Hayran, Serhat Ünal, Ayşe Kars, Emin Kansu.
What is the DOI of this paper?
10.1016/s0924-8579(99)00096-5, permanently at https://doi.org/10.1016/s0924-8579(99)00096-5. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.